LLMpediaThe first transparent, open encyclopedia generated by LLMs

HUGO Gene Nomenclature Committee

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Gene Block Hop 4
Expansion Funnel Raw 39 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted39
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
HUGO Gene Nomenclature Committee
NameHUGO Gene Nomenclature Committee
Founded1979
HeadquartersEuropean Bioinformatics Institute
Key peopleElspeth Bruford (Coordinator)
Parent organizationHuman Genome Organisation
Websitehttps://www.genenames.org/

HUGO Gene Nomenclature Committee. The HUGO Gene Nomenclature Committee is the internationally recognized authority responsible for assigning unique and standardized names and symbols to every human gene. Operating under the auspices of the Human Genome Organisation, the committee's work is fundamental to biomedical research, ensuring consistent communication across disciplines such as genomics, clinical genetics, and molecular biology. Its curated database is an essential resource for major projects like the Human Genome Project and is integrated into key bioinformatics platforms including Ensembl and NCBI.

History and establishment

The committee was established in 1979, arising from a need for systematic gene naming identified during early human gene mapping workshops. Its formation was championed by leading geneticists involved with the Human Genome Organisation, which was itself founded around the same period to coordinate international genomic research. Early work focused on standardizing names for genes located on the X chromosome and the Y chromosome, as well as those within the human leukocyte antigen complex. The advent of the Human Genome Project in the 1990s dramatically increased the urgency and scale of its mission, necessitating a more formalized and scalable nomenclature system.

Purpose and responsibilities

The primary purpose is to approve a unique gene symbol and name for every known human gene, which is then disseminated through its publicly accessible database. This prevents the confusion caused by multiple aliases and synonyms used in different publications and databases. The committee actively works with research communities, consortia like the Genome Reference Consortium, and other nomenclature bodies such as the Mouse Genome Informatics group to ensure cross-species consistency. It also provides guidance on naming novel gene classes, including long non-coding RNA genes and pseudogenes, and resolves conflicting annotations in resources like RefSeq.

Naming conventions and guidelines

Naming conventions prioritize brevity, uniqueness, and relevance to gene function or phenotype. Symbols are typically short, memorable, and in uppercase Latin letters or a combination of letters and Arabic numerals. Where possible, the symbol is based on the gene's known function, as seen with BRCA1 for breast cancer susceptibility, or a homologous gene in a model organism like Drosophila. For genes of unknown function, symbols may reflect cytogenetic location, such as those in the Smith-Magenis syndrome region on chromosome 17. The guidelines are regularly updated to address emerging categories, including RNA genes and gene clusters like those for olfactory receptors.

Impact and recognition

The committee's standardized nomenclature is universally adopted in major scientific journals, including Nature and Science, and is mandated for use in clinical reporting by organizations like the Association for Molecular Pathology. This standardization is critical for integrating data from large-scale projects such as the Cancer Genome Atlas and the 1000 Genomes Project. Its work supports clinical diagnostics, enabling clear identification of disease-associated variants in genes like TP53 and CFTR, and is foundational for the development of tools used in pharmacogenomics and personalized medicine.

Organizational structure and funding

The committee is composed of an international panel of volunteer scientists, each an expert in specific gene families or chromosomal regions, overseen by a full-time coordinator based at the European Bioinformatics Institute in the United Kingdom. Primary funding is provided through grants from the National Institutes of Health in the United States and the Wellcome Trust in the United Kingdom. Additional support comes from its parent body, the Human Genome Organisation, and through collaborations with institutions like the Sanger Institute. The committee operates through a consensus-driven process, reviewing nomenclature proposals submitted by researchers worldwide.

Category:Genetics organizations Category:Scientific nomenclature